The effect of a methadone reformulation on opioid agonist treatment outcomes: A population-based study in British Columbia, Canada, 2013–14

Original research
par
Krebs, Emanuel et al

Date de publication

2021

Géographie

Canada

Langue de la ressource

English

Texte disponible en version intégrale

Non

Open Access / OK to Reproduce

Non

Évalué par des pairs

Yes

L’objectif

The province of British Columbia, Canada, changed the existing oral anhydrous methadone solution to a 10-times more concentrated pre-mixed solution, Methadose®, on February 1, 2014. We aimed to assess the immediate effects of the methadone reformulation on missed doses, days off methadone, changes in medication dosing and dispensations of opioids for pain, and hospitalizations and mortality among all people receiving treatment at or near the time of the change

Constatations/points à retenir

The regulatory change resulted in increases in treatment discontinuation, more instances of methadone dose increases, and was associated with increased prescriptions of other opioid analgesics.

La conception ou méthodologie de recherche

Population-based retrospective cohort study

Mots clés

Policy/Regulatory
About PWUD
Outcomes
Substitution/OAT